K70.3 Alcoholic cirrhosis of liver

Name of the Condition

• Alcoholic Cirrhosis of Liver
• ICD-10 Code: K70.3

Summary

Alcoholic cirrhosis of the liver is a late-stage liver disease resulting from chronic alcohol abuse, characterized by irreversible scarring (fibrosis) that replaces healthy liver tissue. This scarring impairs liver function and can lead to complications such as portal hypertension and liver failure.

Causes

Chronic and excessive alcohol consumption is the primary cause. Prolonged alcohol use triggers inflammation and oxidative stress in the liver, leading to progressive fibrosis and the formation of scar tissue that disrupts normal liver architecture.

Risk Factors

• Prolonged heavy alcohol consumption (typically >20-30 grams/day for women, >40-60 grams/day for men over years).
• Genetic factors influencing alcohol metabolism or susceptibility to liver injury.
• Coexisting conditions like viral hepatitis or non-alcoholic fatty liver disease.
• Poor nutrition, which exacerbates liver damage.
• Gender, with women at higher risk for alcohol-related liver injury at lower intake levels.

Symptoms

• Fatigue, weakness, and malaise.
• Jaundice (yellowing of skin/eyes) due to impaired bilirubin processing.
• Abdominal swelling (ascites) or leg edema from portal hypertension.
• Easy bruising or bleeding (coagulopathy).
• Loss of appetite, weight loss, and nausea.
• Spider angiomas or palmar erythema (vascular changes).
• Enlarged spleen (splenomegaly) or liver (hepatomegaly).

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests assess liver function (e.g., elevated AST/ALT, bilirubin, INR) and rule out other causes. Imaging (ultrasound, CT, or MRI) evaluates liver structure for nodularity or atrophy. A liver biopsy may confirm cirrhosis and assess severity, though often unnecessary if clinical and imaging findings are clear.

Treatment Options

• Complete and sustained alcohol abstinence to halt progression.
• Nutritional support (e.g., high-protein, vitamin-rich diet) to address deficiencies.
• Medications to manage complications (e.g., diuretics for ascites, beta-blockers for varices).
• Liver transplantation for end-stage disease.
• Management of comorbidities (e.g., viral hepatitis, diabetes).

Prognosis and Follow-Up

Prognosis depends on disease stage, abstinence adherence, and presence of complications. Early intervention with abstinence can stabilize or improve mild cases, but advanced cirrhosis may progress to liver failure. Regular follow-up includes monitoring liver function, imaging, and screening for hepatocellular carcinoma (HCC) in at-risk patients.

Complications

• Portal hypertension leading to varices, ascites, or splenomegaly.
• Hepatic encephalopathy (neurological impairment from toxin buildup).
• Hepatocellular carcinoma (HCC).
• Liver failure requiring transplantation.
• Increased risk of infections due to impaired immune function.

Lifestyle & Prevention

• Abstain from alcohol entirely to prevent progression.
• Maintain a balanced diet with adequate protein and vitamins.
• Avoid hepatotoxic substances (e.g., certain medications, supplements).
• Vaccinate against hepatitis A and B to reduce additional liver stress.
• Regular exercise and weight management (if applicable) to support overall health.

When to Seek Professional Help

Seek immediate care for symptoms like severe abdominal pain, confusion, jaundice, or uncontrolled bleeding. Ongoing monitoring is critical for those with diagnosed cirrhosis, even if asymptomatic, to detect complications early.

Tips for Medical Coders

Document the presence of cirrhosis and its alcoholic etiology clearly. Code K70.3 is specific to alcoholic cirrhosis; ensure clinical documentation supports this diagnosis without ambiguity. Note any associated complications (e.g., ascites, varices) for additional coding, but avoid adding unrelated conditions. Verify that alcohol use is confirmed as the primary cause to justify this code.